From Early Morphometrics to Machine Learning—What Future for Cardiovascular Imaging of the Pulmonary Circulation?

Imaging plays a cardinal role in the diagnosis and management of diseases of the pulmonary circulation. Behind the picture itself, every digital image contains a wealth of quantitative data, which are hardly analysed in current routine clinical practice and this is now being transformed by radiomics...

Full description

Bibliographic Details
Main Authors: Deepa Gopalan, J. Simon R. Gibbs
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/10/12/1004
id doaj-34d01f8460c341169c33b46300d15f0d
record_format Article
spelling doaj-34d01f8460c341169c33b46300d15f0d2020-11-27T08:02:58ZengMDPI AGDiagnostics2075-44182020-11-01101004100410.3390/diagnostics10121004From Early Morphometrics to Machine Learning—What Future for Cardiovascular Imaging of the Pulmonary Circulation?Deepa Gopalan0J. Simon R. Gibbs1Imperial College Healthcare NHS Trust, London W12 0HS, UKImperial College London, London SW7 2AZ, UKImaging plays a cardinal role in the diagnosis and management of diseases of the pulmonary circulation. Behind the picture itself, every digital image contains a wealth of quantitative data, which are hardly analysed in current routine clinical practice and this is now being transformed by radiomics. Mathematical analyses of these data using novel techniques, such as vascular morphometry (including vascular tortuosity and vascular volumes), blood flow imaging (including quantitative lung perfusion and computational flow dynamics), and artificial intelligence, are opening a window on the complex pathophysiology and structure–function relationships of pulmonary vascular diseases. They have the potential to make dramatic alterations to how clinicians investigate the pulmonary circulation, with the consequences of more rapid diagnosis and a reduction in the need for invasive procedures in the future. Applied to multimodality imaging, they can provide new information to improve disease characterization and increase diagnostic accuracy. These new technologies may be used as sophisticated biomarkers for risk prediction modelling of prognosis and for optimising the long-term management of pulmonary circulatory diseases. These innovative techniques will require evaluation in clinical trials and may in themselves serve as successful surrogate end points in trials in the years to come.https://www.mdpi.com/2075-4418/10/12/1004pulmonary vascular morphometricspulmonary vascular imagingpulmonary perfusion imagingblood flow imagingAI and pulmonary vasculaturemachine learning and pulmonary circulation
collection DOAJ
language English
format Article
sources DOAJ
author Deepa Gopalan
J. Simon R. Gibbs
spellingShingle Deepa Gopalan
J. Simon R. Gibbs
From Early Morphometrics to Machine Learning—What Future for Cardiovascular Imaging of the Pulmonary Circulation?
Diagnostics
pulmonary vascular morphometrics
pulmonary vascular imaging
pulmonary perfusion imaging
blood flow imaging
AI and pulmonary vasculature
machine learning and pulmonary circulation
author_facet Deepa Gopalan
J. Simon R. Gibbs
author_sort Deepa Gopalan
title From Early Morphometrics to Machine Learning—What Future for Cardiovascular Imaging of the Pulmonary Circulation?
title_short From Early Morphometrics to Machine Learning—What Future for Cardiovascular Imaging of the Pulmonary Circulation?
title_full From Early Morphometrics to Machine Learning—What Future for Cardiovascular Imaging of the Pulmonary Circulation?
title_fullStr From Early Morphometrics to Machine Learning—What Future for Cardiovascular Imaging of the Pulmonary Circulation?
title_full_unstemmed From Early Morphometrics to Machine Learning—What Future for Cardiovascular Imaging of the Pulmonary Circulation?
title_sort from early morphometrics to machine learning—what future for cardiovascular imaging of the pulmonary circulation?
publisher MDPI AG
series Diagnostics
issn 2075-4418
publishDate 2020-11-01
description Imaging plays a cardinal role in the diagnosis and management of diseases of the pulmonary circulation. Behind the picture itself, every digital image contains a wealth of quantitative data, which are hardly analysed in current routine clinical practice and this is now being transformed by radiomics. Mathematical analyses of these data using novel techniques, such as vascular morphometry (including vascular tortuosity and vascular volumes), blood flow imaging (including quantitative lung perfusion and computational flow dynamics), and artificial intelligence, are opening a window on the complex pathophysiology and structure–function relationships of pulmonary vascular diseases. They have the potential to make dramatic alterations to how clinicians investigate the pulmonary circulation, with the consequences of more rapid diagnosis and a reduction in the need for invasive procedures in the future. Applied to multimodality imaging, they can provide new information to improve disease characterization and increase diagnostic accuracy. These new technologies may be used as sophisticated biomarkers for risk prediction modelling of prognosis and for optimising the long-term management of pulmonary circulatory diseases. These innovative techniques will require evaluation in clinical trials and may in themselves serve as successful surrogate end points in trials in the years to come.
topic pulmonary vascular morphometrics
pulmonary vascular imaging
pulmonary perfusion imaging
blood flow imaging
AI and pulmonary vasculature
machine learning and pulmonary circulation
url https://www.mdpi.com/2075-4418/10/12/1004
work_keys_str_mv AT deepagopalan fromearlymorphometricstomachinelearningwhatfutureforcardiovascularimagingofthepulmonarycirculation
AT jsimonrgibbs fromearlymorphometricstomachinelearningwhatfutureforcardiovascularimagingofthepulmonarycirculation
_version_ 1724413883634941952